Inpharma Weekly

, Volume 795, Issue 1, pp 6–6 | Cite as

Improved survival with streptokinase therapy after myocardial infarction is worth the extra cost

Newsletter Article


Streptokinase Thrombolytic Therapy Lifetime Cost Health Care Provision Anterior Infarction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1991

Personalised recommendations